|Expense Ratio (net)||1.02%|
|Last Cap Gain||0.00|
|Morningstar Risk Rating||Above Average|
|5y Average Return||N/A|
|Average for Category||N/A|
|Inception Date||Sep 15, 1997|
The decline in biotech stocks is momentary and we expect the industry to bounce back in the coming days. So consider investing in these three biotech mutual funds.
Biotech stocks have taken off since President Trump took office. Through the end of July, the iShares Biotech ETF is up almost 19%, well ahead of broader market benchmarks. If you are thinking of investing in biotech stocks after this rally, here's what you need to know.